Sagent Pharmaceuticals RX
FDA Approved Drugs

Sagent Pharmaceuticals RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 41
  • Latest Approval Date Mar 26, 2026
  • Data Source FDA
  • First Approval Date Jan 27, 1995
All
52
View
Unclassified
2
View
Discontinued
9
View
RX
41
View
Company Overview

Company

Sagent Pharmaceuticals RX

Country

U.S.A

Website

Visit Website

Email

jsinger@sagentpharma.com

Social Profiles

Company Snapshot

Sagent Pharmaceuticals RX

1901 N. Roselle Rd.Schaumburg, IL 60195

U.S.A

www.sagentpharma.com/ jsinger@sagentpharma.com View on Map
FDA Approved Drug Records ( 41 records )
1995
27 Jan
RX Application: 74441

Drug Name

BUMETANIDE

Product Number

1

Dosage Form

-

Strength

0.25MG/ML

Approval Date

1995-01-27

74441 / 1

Active Ingredient

BUMETANIDE

Application Number

74441

Product Number

1

Dosage Form

-

Strength

0.25MG/ML

Approval Date

1995-01-27

Regulatory Status

RX

2012
29 Aug
RX Application: 90827

Drug Name

CAFFEINE CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2012-08-29

90827 / 1

Active Ingredient

CAFFEINE CITRATE

Application Number

90827

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2012-08-29

Regulatory Status

RX

2012
29 Aug
RX Application: 91102

Drug Name

CAFFEINE CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2012-08-29

91102 / 1

Active Ingredient

CAFFEINE CITRATE

Application Number

91102

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2012-08-29

Regulatory Status

RX

2025
09 Jul
RX Application: 219196

Drug Name

CALCITONIN-SALMON

Product Number

1

Dosage Form

-

Strength

200 IU/ML

Approval Date

2025-07-09

219196 / 1

Active Ingredient

CALCITONIN SALMON

Application Number

219196

Product Number

1

Dosage Form

-

Strength

200 IU/ML

Approval Date

2025-07-09

Regulatory Status

RX

2025
30 Dec
RX Application: 219619

Drug Name

CALCIUM GLUCONATE IN SODIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

1GM/50ML (20MG/ML)

Approval Date

2025-12-30

219619 / 1

Active Ingredient

CALCIUM GLUCONATE

Application Number

219619

Product Number

1

Dosage Form

-

Strength

1GM/50ML (20MG/ML)

Approval Date

2025-12-30

Regulatory Status

RX

2025
30 Dec
RX Application: 219619

Drug Name

CALCIUM GLUCONATE IN SODIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

2GM/100ML (20MG/ML)

Approval Date

2025-12-30

219619 / 2

Active Ingredient

CALCIUM GLUCONATE

Application Number

219619

Product Number

2

Dosage Form

-

Strength

2GM/100ML (20MG/ML)

Approval Date

2025-12-30

Regulatory Status

RX

1996
28 Feb
RX Application: 74617

Drug Name

DILTIAZEM HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG/ML

Approval Date

1996-02-28

74617 / 1

Active Ingredient

DILTIAZEM HYDROCHLORIDE

Application Number

74617

Product Number

1

Dosage Form

-

Strength

5MG/ML

Approval Date

1996-02-28

Regulatory Status

RX

2013
18 Mar
RX Application: 91495

Drug Name

DOXORUBICIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

2013-03-18

91495 / 1

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Application Number

91495

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

2013-03-18

Regulatory Status

RX

2001
16 Apr
RX Application: 75651

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-16

75651 / 1

Active Ingredient

FAMOTIDINE

Application Number

75651

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-16

Regulatory Status

RX

2001
16 Apr
RX Application: 75684

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-16

75684 / 1

Active Ingredient

FAMOTIDINE

Application Number

75684

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-16

Regulatory Status

RX

2001
16 Apr
RX Application: 75622

Drug Name

FAMOTIDINE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-16

75622 / 1

Active Ingredient

FAMOTIDINE

Application Number

75622

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-16

Regulatory Status

RX

2001
17 Apr
RX Application: 75825

Drug Name

FAMOTIDINE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-17

75825 / 1

Active Ingredient

FAMOTIDINE

Application Number

75825

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2001-04-17

Regulatory Status

RX

2012
28 Aug
RX Application: 90584

Drug Name

FLUMAZENIL

Product Number

1

Dosage Form

-

Strength

0.5MG/5ML (0.1MG/ML)

Approval Date

2012-08-28

90584 / 1

Active Ingredient

FLUMAZENIL

Application Number

90584

Product Number

1

Dosage Form

-

Strength

0.5MG/5ML (0.1MG/ML)

Approval Date

2012-08-28

Regulatory Status

RX

2012
28 Aug
RX Application: 90584

Drug Name

FLUMAZENIL

Product Number

2

Dosage Form

-

Strength

1MG/10ML (0.1MG/ML)

Approval Date

2012-08-28

90584 / 2

Active Ingredient

FLUMAZENIL

Application Number

90584

Product Number

2

Dosage Form

-

Strength

1MG/10ML (0.1MG/ML)

Approval Date

2012-08-28

Regulatory Status

RX

2021
27 Jan
RX Application: 214766

Drug Name

FUROSEMIDE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2021-01-27

214766 / 1

Active Ingredient

FUROSEMIDE

Application Number

214766

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2021-01-27

Regulatory Status

RX

2020
21 Feb
RX Application: 210083

Drug Name

GLYCOPYRROLATE

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2020-02-21

210083 / 1

Active Ingredient

GLYCOPYRROLATE

Application Number

210083

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2020-02-21

Regulatory Status

RX

2011
02 Sep
RX Application: 91637

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2011-09-02

91637 / 1

Active Ingredient

HALOPERIDOL LACTATE

Application Number

91637

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2011-09-02

Regulatory Status

RX

2011
02 Sep
RX Application: 200742

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2011-09-02

200742 / 1

Active Ingredient

HALOPERIDOL LACTATE

Application Number

200742

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2011-09-02

Regulatory Status

RX

2010
30 Jun
RX Application: 90808

Drug Name

HEPARIN SODIUM

Product Number

1

Dosage Form

-

Strength

1,000 UNITS/ML

Approval Date

2010-06-30

90808 / 1

Active Ingredient

HEPARIN SODIUM

Application Number

90808

Product Number

1

Dosage Form

-

Strength

1,000 UNITS/ML

Approval Date

2010-06-30

Regulatory Status

RX

2010
30 Jun
RX Application: 90808

Drug Name

HEPARIN SODIUM

Product Number

2

Dosage Form

-

Strength

5,000 UNITS/ML

Approval Date

2010-06-30

90808 / 2

Active Ingredient

HEPARIN SODIUM

Application Number

90808

Product Number

2

Dosage Form

-

Strength

5,000 UNITS/ML

Approval Date

2010-06-30

Regulatory Status

RX

2010
30 Jun
RX Application: 90808

Drug Name

HEPARIN SODIUM

Product Number

3

Dosage Form

-

Strength

10,000 UNITS/ML

Approval Date

2010-06-30

90808 / 3

Active Ingredient

HEPARIN SODIUM

Application Number

90808

Product Number

3

Dosage Form

-

Strength

10,000 UNITS/ML

Approval Date

2010-06-30

Regulatory Status

RX

2010
30 Jun
RX Application: 90809

Drug Name

HEPARIN SODIUM

Product Number

1

Dosage Form

-

Strength

20,000 UNITS/ML

Approval Date

2010-06-30

90809 / 1

Active Ingredient

HEPARIN SODIUM

Application Number

90809

Product Number

1

Dosage Form

-

Strength

20,000 UNITS/ML

Approval Date

2010-06-30

Regulatory Status

RX

2010
30 Jun
RX Application: 90810

Drug Name

HEPARIN SODIUM PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

1,000 UNITS/ML

Approval Date

2010-06-30

90810 / 1

Active Ingredient

HEPARIN SODIUM

Application Number

90810

Product Number

1

Dosage Form

-

Strength

1,000 UNITS/ML

Approval Date

2010-06-30

Regulatory Status

RX

2012
06 Sep
RX Application: 200753

Drug Name

LEUCOVORIN CALCIUM PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2012-09-06

200753 / 1

Active Ingredient

LEUCOVORIN CALCIUM

Application Number

200753

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2012-09-06

Regulatory Status

RX

2012
06 Sep
RX Application: 200753

Drug Name

LEUCOVORIN CALCIUM PRESERVATIVE FREE

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2012-09-06

200753 / 2

Active Ingredient

LEUCOVORIN CALCIUM

Application Number

200753

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2012-09-06

Regulatory Status

RX

2012
06 Sep
RX Application: 200753

Drug Name

LEUCOVORIN CALCIUM PRESERVATIVE FREE

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

2012-09-06

200753 / 3

Active Ingredient

LEUCOVORIN CALCIUM

Application Number

200753

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

2012-09-06

Regulatory Status

RX

2012
06 Sep
RX Application: 200855

Drug Name

LEUCOVORIN CALCIUM PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 350MG BASE/VIAL

Approval Date

2012-09-06

200855 / 1

Active Ingredient

LEUCOVORIN CALCIUM

Application Number

200855

Product Number

1

Dosage Form

-

Strength

EQ 350MG BASE/VIAL

Approval Date

2012-09-06

Regulatory Status

RX

2013
26 Jun
RX Application: 91627

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

500MG/5ML (100MG/ML)

Approval Date

2013-06-26

91627 / 1

Active Ingredient

LEVETIRACETAM

Application Number

91627

Product Number

1

Dosage Form

-

Strength

500MG/5ML (100MG/ML)

Approval Date

2013-06-26

Regulatory Status

RX

2012
24 Aug
RX Application: 90580

Drug Name

NAFCILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2012-08-24

90580 / 1

Active Ingredient

NAFCILLIN SODIUM

Application Number

90580

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2012-08-24

Regulatory Status

RX

2012
24 Aug
RX Application: 90582

Drug Name

NAFCILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2012-08-24

90582 / 1

Active Ingredient

NAFCILLIN SODIUM

Application Number

90582

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2012-08-24

Regulatory Status

RX

2012
24 Aug
RX Application: 90582

Drug Name

NAFCILLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2012-08-24

90582 / 2

Active Ingredient

NAFCILLIN SODIUM

Application Number

90582

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2012-08-24

Regulatory Status

RX

2025
11 Aug
RX Application: 219692

Drug Name

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)

Approval Date

2025-08-11

219692 / 1

Active Ingredient

NOREPINEPHRINE BITARTRATE

Application Number

219692

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)

Approval Date

2025-08-11

Regulatory Status

RX

2025
11 Aug
RX Application: 219692

Drug Name

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

Product Number

2

Dosage Form

-

Strength

EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)

Approval Date

2025-08-11

219692 / 2

Active Ingredient

NOREPINEPHRINE BITARTRATE

Application Number

219692

Product Number

2

Dosage Form

-

Strength

EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)

Approval Date

2025-08-11

Regulatory Status

RX

2026
26 Mar
RX Application: 220483

Drug Name

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

Product Number

1

Dosage Form

-

Strength

EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)

Approval Date

2026-03-26

220483 / 1

Active Ingredient

NOREPINEPHRINE BITARTRATE

Application Number

220483

Product Number

1

Dosage Form

-

Strength

EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)

Approval Date

2026-03-26

Regulatory Status

RX

2011
30 Aug
RX Application: 90585

Drug Name

ORPHENADRINE CITRATE

Product Number

1

Dosage Form

-

Strength

30MG/ML

Approval Date

2011-08-30

90585 / 1

Active Ingredient

ORPHENADRINE CITRATE

Application Number

90585

Product Number

1

Dosage Form

-

Strength

30MG/ML

Approval Date

2011-08-30

Regulatory Status

RX

2012
30 Mar
RX Application: 91245

Drug Name

OXACILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2012-03-30

91245 / 1

Active Ingredient

OXACILLIN SODIUM

Application Number

91245

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2012-03-30

Regulatory Status

RX

2004
28 May
RX Application: 40540

Drug Name

PROCHLORPERAZINE EDISYLATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2004-05-28

40540 / 1

Active Ingredient

PROCHLORPERAZINE EDISYLATE

Application Number

40540

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2004-05-28

Regulatory Status

RX

2011
26 Jan
RX Application: 91284

Drug Name

TOPOTECAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/VIAL

Approval Date

2011-01-26

91284 / 1

Active Ingredient

TOPOTECAN HYDROCHLORIDE

Application Number

91284

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/VIAL

Approval Date

2011-01-26

Regulatory Status

RX

2002
14 Nov
RX Application: 76295

Drug Name

VALPROATE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/ML

Approval Date

2002-11-14

76295 / 1

Active Ingredient

VALPROATE SODIUM

Application Number

76295

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/ML

Approval Date

2002-11-14

Regulatory Status

RX

2012
10 Aug
RX Application: 200837

Drug Name

VANCOMYCIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 5GM BASE/VIAL

Approval Date

2012-08-10

200837 / 1

Active Ingredient

VANCOMYCIN HYDROCHLORIDE

Application Number

200837

Product Number

1

Dosage Form

-

Strength

EQ 5GM BASE/VIAL

Approval Date

2012-08-10

Regulatory Status

RX

2014
02 Sep
RX Application: 200837

Drug Name

VANCOMYCIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2014-09-02

200837 / 2

Active Ingredient

VANCOMYCIN HYDROCHLORIDE

Application Number

200837

Product Number

2

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2014-09-02

Regulatory Status

RX

Related Databases
  • FDA Inspections
    8 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    52 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
41 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BUMETANIDE

Application Number

74441

Product Number

1

Active Ingredient

BUMETANIDE

Dosage Form

-

Strength

0.25MG/ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit